Aura Biosciences, Inc. announced that it will receive $80,483,829 in funding on March 17, 2021. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.05 USD | -4.73% |
|
-1.26% | -20.43% |
May. 29 | Transcript : Aura Biosciences, Inc. - Special Call | |
May. 09 | Aura Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.43% | 349M | |
+34.01% | 51.07B | |
-8.02% | 38.78B | |
+35.48% | 38.86B | |
-11.12% | 26.69B | |
+12.56% | 26.35B | |
-19.62% | 19.46B | |
+39.18% | 13.58B | |
+31.47% | 12.46B | |
-3.40% | 11.75B |
- Stock Market
- Equities
- AURA Stock
- News Aura Biosciences, Inc.
- Aura Biosciences, Inc. announced that it expects to receive $80.483829 million in funding